Coronavirus Update: Paxlovid Moves Towards EU Approval, Moderna Targets Omicron
Plus, New China Alliance, Daiichi Assesses mRNA Booster
Pfizer gets European Commission approval for Paxlovid after a positive CHMP opinion, while Moderna started a Phase II study of its Omicron-specific vaccine candidate. Meanwhile, China's Junshi enters into a new oral antiviral collaboration while Daiichi Sankyo investigates its mRNA vaccine contender as a booster shot.
